Researchers create genetic map tied to kidney disease
New research from Penn Medicine reveals over 1,000 genes linked to kidney disease, offering hope for better diagnoses and targeted treatments for kidney patients.
United Therapeutics’ Gene-Edited Kidney Xenotranspant UKidney Cleared for US Trial
United Therapeutics has received FDA clearance to test UKidney, a gene-edited pig kidney designed for human transplant. The first trials are expected to begin in 2025.
Making kidney tests work for everyone
For decades, kidney function tests used a race correction that delayed diagnosis for Black patients. The medical community is now fixing this critical equity issue.
New AI Tool May Boost Success for Kidney Transplant Patients
A Breakthrough in Kidney Transplant Prediction For those living with kidney disease and waiting for a transplant, the uncertainty can be overwhelming. But a newly developed artificial intelligence tool, the UK Deceased Donor Kidney Transplant Outcome Prediction (UK-DTOP) tool, is offering fresh hope. This groundbreaking technology aims to improve donor-recipient matching and enhance the efficiency […]
New trial to test potential treatment for chronic kidney disease
The EASi-KIDNEY trial is investigating whether vicadrostat combined with empagliflozin can slow kidney disease progression better than existing treatments.
More families refusing to donate relatives’ organs
Family refusal rates for organ donation are rising, leaving hundreds of kidney patients on waiting lists. Open conversations about donation can help change this.
Transplant footballers lace up for first world cup
England’s transplant recipients are preparing for the inaugural Transplant Football World Cup in Italy, proving that life after organ transplant is full and active.
Surprising mechanism of lupus kidney damage identified
A groundbreaking study reveals innate lymphoid cells may be the primary drivers of lupus kidney damage, offering new insights for treatment.
Novartis receives FDA accelerated approval for Fabhalta®
Novartis receives FDA accelerated approval for Fabhalta, a breakthrough treatment offering new hope for IgA nephropathy patients.
Diabetes fuelling kidney disease timebomb as transplant list at a high
Type 2 diabetes is fuelling a kidney disease crisis in the UK, with transplant lists at their highest in a decade.